Emerald Mutual Fund Advisers Trust’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,314	Closed	-$2.23M	–	299
2015 Q3	$2.23M	Buy	15,314 +776	+5%	+$142K	0.15%	152
2015 Q2	$3.09M	Sell	14,538 -1,933	-12%	-$474K	0.24%	115
2015 Q1	$4.13M	Sell	16,471 -250	-1%	-$60.5K	0.34%	95
2014 Q4	$3.85M	Buy	+16,721	New	+$3.59M	0.33%	93

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's BLCM Position: Q4 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2015, closing a stake of 15,314 shares — an estimated $2.23M sold.

Emerald Mutual Fund Advisers Trust first reported a position in BLCM in Q4 2014 and held it in 4 quarters. The position peaked at $4.13M in Q1 2015. 81 funds tracked by Wall St. Rank hold BLCM as of Q4 2015.

Emerald Mutual Fund Advisers Trust reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 15,314 Bellicum Pharmaceuticals, Inc. shares in Q4 2015, an estimated $2.23M.
Emerald Mutual Fund Advisers Trust first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
Emerald Mutual Fund Advisers Trust's Bellicum Pharmaceuticals, Inc. position peaked at $4.13M in Q1 2015.
81 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2015, filed 25 Jan 2016.